Filter
89
Filtered Results: 89
Text search:
Global
Initiative
for
Chronic
Obstructive
Lung
Disease
–
GOLD
Featured
Recommendations
11
New Publications
18
Language
Document type
No document type
35
Studies & Reports
24
Guidelines
20
Strategic & Response Plan
5
Manuals
2
Training Material
1
Videos
1
Fact sheets
1
Countries / Regions
Global
24
India
5
Philippines
4
South Africa
4
Tanzania
3
Ghana
2
Nigeria
2
Africa
2
Western and Central Europe
2
Eastern Europe
2
Ethiopia
2
Kenya
1
Ukraine
1
Mozambique
1
Guinea-Bissau
1
Latin America and the Carribbean
1
Germany
1
South–East Asia Region
1
Western Pacific Region
1
Paraguay
1
Argentina
1
Uganda
1
Russia
1
Namibia
1
Georgia
1
Angola
1
Botswana
1
Zambia
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Non-communicable Diseases
24
Guidelines
18
Policies & Guidelines HIV & TB
9
TB
6
Pediatrics
4
Capacity Building
4
Child Health
3
Policies
2
Drugs & Medical Equipment
2
Paediatrics
1
Public Health
1
Diabetes
1
Humanitarian Aid
1
COVID-19
1
Infection Control & Prevention (IPC)
1
Countries
1
NCD
1
Demograhic Health Surveys DHS
1
Community Health
1
Studies & Reports
1
Age & Elderly
1
Radiology and Diagnostic
1
Toolboxes
Prevention & Strategies
11
Clinical Aspects & Diagnosis
7
Clinical Guidelines
4
Clinical Aspects & Diagnosis
4
Studies & Reports
4
Adults
3
Clean air
3
Country Guidelines
2
Essential Medicines & Medical Devices
2
Information & Education Material (IEC)
2
Detection & Diagnosis
2
Disease Prevention & Control
2
Childhood TB
1
Prevention & Control
1
Curricula & Core Competencies
1
Children
1
Georgia
1
Ethiopia
1
Climate & Health
1
Cannabis
1
Training, others
1
For Health Worker
1
Country specific documents
1
Paediatrics
1
Medical & Community Masks
1
Oxygen Therapy
1
Planetary Health
1
Urban health
1
HIV &TB
1
Environment
1
Overview, Studies & Reports
1
Prevention & Strategies
1
Clinical Aspects & Diagnosis
1
Air Pollution
1
Capacity Building & Resources
1
Botswana
1
Ghana
1
Substance Use Disorders & Addiction
1
Germany
1
Uganda
1
Tobacco
1
Clinical Guidelines
1
TB
1
Reports & Studies
1
Eastern Europe and central Asia
1
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for...
The World Heart Federation (WHF) commenced a Roadmap initiative in 2015 to reduce the global burden of cardiovascular disease and resultant burgeoning of healthcare costs. Roadmaps provide a blueprint for implementation of priority solutions for the principal cardiovascular diseases leading to death...
Long Acting Muscarinic Antagonists (LAMA) such as tiotropium and glycopyrronium are used in the management of COPD1. They have been shown to improve lung function, quality of life and exercise tolerance. They have also been associated with reduced COPD-related exacerbations, associated hospitalisati...
There is increasing interest in understanding the role of air pollution as one of the greatest threats to human health worldwide. Nine of 10 individuals breathe air with polluted compounds that have a great impact on lung tissue. The nature of the relationship is complex, and new or updated data are...
Care for persons with noncommunicable diseases (NCDs), such as cardiovascular disease, diabetes, cancer, and chronic obstructive pulmonary disease, is a major health priority for most countries worldwide, particularly for low-middle income countries where the problem seems to be worsening. Globally,...
The article "Under- and over-diagnosis of COPD: a global perspective" reviews the worldwide variation in the prevalence of chronic obstructive pulmonary disease (COPD) and issues related to its misdiagnosis. It highlights that COPD is under-diagnosed due to factors such as limited access to spiromet...
There is paucity of data on the burden and specific drivers operative in the pathogenesis of chronic obstructive pulmonary disease (COPD) in the African setting and populations. Lack of awareness and inadequate knowledge on the aetio-pathogenesis of the disease together with inadequate capacity for ...
The GOLD website is dedicated to providing comprehensive information on Chronic Obstructive Pulmonary Disease (COPD). It offers resources and guidelines for healthcare professionals and public health authorities to improve the diagnosis, management, and prevention of COPD worldwide. The site include...
The article outlines the prioritized research agenda for the prevention and control of chronic respiratory diseases (CRDs) as part of the World Health Organization's (WHO) action plan on noncommunicable diseases (NCDs) from 2008 to 2013. It highlights the significant global impact of CRDs, including...
The GOLD 2023 report provides a comprehensive update on the global strategy for diagnosing, managing, and preventing chronic obstructive pulmonary disease (COPD). It emphasizes that COPD is a leading cause of death worldwide, driven by risk factors such as tobacco smoking, air pollution, and genetic...
The "GOLD Patient Guide 2019" explains Chronic Obstructive Pulmonary Disease (COPD), its causes, symptoms, and stages. It provides practical advice for managing COPD, including the importance of quitting smoking, following medical treatment plans, exercising, maintaining a healthy diet, and creating...
The aim of the GOLD Report is to provide a non-biased review of the current evidence for the assessment, diagnosis and treatment of people with COPD. One of the strengths of GOLD reports is the treatment objectives. These have stood the test of time, and are organized into two groups: objectives tha...
Chronic Obstructive Pulmonary Disease (COPD) is now one of the top three causes of death worldwide and 90% of these deaths occur in low- and middle-income countries (LMICs).
More than 3 million people died of COPD in 2012 accounting for 6% of all deaths globally. COPD represents an important public...
Chronic obstructive pulmonary disease (COPD) is a complex disease that requires differential diagnosis and proper classification to identify appropriate therapy. Nonpharmacologic therapy and preventative measures should be utilized to prevent worsening of disease, symptoms, and complications. The Gl...
These podcasts are produced for educational discussions only. Reference to any specific product, treatment, or entity does not constitute an endorsement. The views expressed by speakers are their own and do not necessarily reflect the view of GOLD in entirety.
Over the past 20 years, the Global Initiative for Asthma (GINA) has regularly published and annually updated a global strategy for asthma management and prevention that has formed the basis for many national guidelines. However, uptake of existing guidelines is poor. A major revision of the GINA r...
The 2023 update of the Global Strategy for Asthma Management and Prevention incorporates new scientific information about asthma based on a review of recent scientific literature by an international panel of experts on the GINA Science Committee. This comprehensive and practical resource about one o...
Chronic respiratory diseases, such as asthma and
chronic obstructive pulmonary disease, kill more than
four million people every year and affect hundreds
of millions more. These diseases erode the health
and well-being of the patients and have a negative
impact on families and societies. Women ...
Chronic respiratory diseases, such as asthma and
chronic obstructive pulmonary disease, kill more than
four million people every year and affect hundreds
of millions more. These diseases erode the health
and well-being of the patients and have a negative
impact on families and societies. Women ...
Over 90% of the morbidity and mortality related to chronic obstructive pulmonary disease (COPD) and asthma occurs in low-income and middle-income countries (LMICs) due to well documented factors including decreased access to screening, trained health professionals, and therapies for disease manageme...
